Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) EBIT (2018 - 2025)

Verastem (VSTM) has 8 years of EBIT data on record, last reported at -$41.5 million in Q4 2025.

  • For Q4 2025, EBIT fell 31.29% year-over-year to -$41.5 million; the TTM value through Dec 2025 reached -$170.1 million, down 47.99%, while the annual FY2025 figure was -$170.1 million, 47.99% down from the prior year.
  • EBIT reached -$41.5 million in Q4 2025 per VSTM's latest filing, down from -$40.7 million in the prior quarter.
  • Across five years, EBIT topped out at -$14.1 million in Q1 2021 and bottomed at -$44.2 million in Q1 2025.
  • Average EBIT over 5 years is -$25.6 million, with a median of -$20.8 million recorded in 2023.
  • The widest YoY moves for EBIT: up 46.48% in 2021, down 198.86% in 2021.
  • A 5-year view of EBIT shows it stood at -$16.5 million in 2021, then dropped by 2.03% to -$16.8 million in 2022, then plummeted by 84.85% to -$31.1 million in 2023, then decreased by 1.45% to -$31.6 million in 2024, then crashed by 31.29% to -$41.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$41.5 million in Q4 2025, -$40.7 million in Q3 2025, and -$43.8 million in Q2 2025.